Joumana Zeid has over 15 years of experience working on drug development as well as drug/device combination products. She started her career at Genentech where she held a variety of roles in Bioprocess Development, Device Development, and gRED Portfolio Management & Operations. Joumana then transitioned to working for smaller companies including Plexxikon and Achaogen where she had Project Management and Team Leadership roles. She is currently a Director and Project Team Leader in the Product and Portfolio Management organization at Aimmune Therapeutics where she is responsible for leading the cross-functional early development teams that develop the company’s clinical assets. Joumana has an MS in Chemical Engineering from SJSU and an MBA from UNC Kenan-Flagler.
